Synthetic studies of complex immunostimulants from Quillaja saponaria: Synthesis of the potent clinical immunoadjuvant QS-21Aapi

Journal of the American Chemical Society

Volumn 128, Issue 36, 2006, Pages 11906-11915

  Kim, Yong Jae ^b   Wang, Pengfei ^b   Navarro Villalobos, Mauricio ^b   Ronde, Bridget D ^b   Derryberry, JohnMark ^b   Gin, David Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; DISEASES; DRUG DOSAGE; IMMUNOLOGY; SYNTHESIS (CHEMICAL); TUMORS; VACCINES;

ADJUVANTS; IMMUNOSTIMULATORY ADJUVANT; NONNATURAL SAPONIN; QUILLAJA SAPONARIA;

DRUG PRODUCTS;

IMMUNOLOGICAL ADJUVANT; PLANT EXTRACT; QS 21; QS 21 A API; QUILLAJA SAPONARIA EXTRACT; SAPONIN; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELLULAR IMMUNITY; CLINICAL STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOPOTENTIATION; IMMUNOSTIMULATION; LUNG SMALL CELL CANCER; MALARIA; MELANOMA; PROSTATE CANCER; QUILLAJA; QUILLAJA SAPONARIA; T LYMPHOCYTE; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; CARBOHYDRATE SEQUENCE; MOLECULAR SEQUENCE DATA; OLEANOLIC ACID; QUILLAJA; SAPOGENINS; SAPONINS; TRISACCHARIDES;

EID: 33748487165     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja062364i     Document Type: Article

References (49)

1. (a) Barr, I. G.; Mitchell, G. F. Immunol. Cell Biol. 1996, 74, 8.
2. (b) Sjölander, A.; Cox, J. C. Adv. Drug Delivery Rev. 1998, 34, 321.
3. Dalsgaard, K. Arch. Gesamte Virusforsch. 1974, 44, 243.
4. Kensil, C. R.; Patel, U.; Lennick, M.; Marciani, D. J. Immunol. 1991. 148, 431-437.
5. Kensil, C. R. Crit. Rev. Ther. Drug Carrier Syst. 1996, 13, 1-55.
6. (a) Jacobsen, N. E.; Fairbrother, W. J.; Kensil, C. R.; Lim, A.; Wheeler, D. A.; Powell, M. F. Carbohydr. Res. 1996. 280, 1.
7. (b) Zhu, X.; Yu, B.; Hui, Y.; Higuchi, R.; Kusano, T.; Miyamoto, T. Tetrahedron Lett. 2000, 41, 717.
8. Ragupathi, G.; Livingston, P. O.; Hood, C.; Gathuru, J.; Krown, S. E.; Chapman, P. B.; Wolchok, J. D.; Williams, L. J.; Oldfield, R. C.; Hwu, W.-J. Clin. Cancer Res. 2003, 9, 5214.
9. Slovin, S. F.; Ragupathi, G.; Adluri, S.; Ungers, G.; Terry, K.; Kim, S.; Spassova, M.; Bornmann, W. G.; Fazzari, M.; Dantis, L.; Olkiewicz, K.; Lloyd, K. O.; Livingston, P. O.; Danishefsky, S. J.; Scher, H. I. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 5710.
10. Gilewski, T.; Ragupathi, G.; Bhuta, S.; Williams, L. J.; Musselli, C.; Zhang, X.-F.; Bencsath, K. P.; Panageas, K. S.; Chin, J.; Hudis, C. A.; Norton, L.; Houghton, A. N.; Livingston, P. O.; Danishefsky, S. J. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 3270.
11. Kim, S. K.; Ragupathi, G.; Cappello, S.; Kagan, E.; Livingston, P. O. Vaccine 2001, 19, 530.
12. Krug, L. M.; Ragupathi, G.; Ng, K. K.; Hood, C.; Jennings, H. J.; Guo, Z.; Kris, M. G.; Miller, V.; Pizzo, B.; Tyson, L.; Baez, V.; Livingston P. O. Clin. Cancer Res. 2004, 10, 916.
13. (a) Newman, M. J.; Wu, J. Y.; Gardner, B. H.; Anderson, C. A.; Kensil, C. R.; Recchia, J.; Coughlin, R. T.; Powell, M. F. Vaccine 1997, 15, 1001.
14. (b) Evans, T. G.; McElrath, M. J.; Matthews, T.; Montefiori, D.; Weinhold, K.; Wolff, M.; Keefer, M. C.; Kallas, E. G.; Corey, L.; Gorse, G. J.; Belshe, R.; Graham, B. S.; Spearman, P. W.; Schwartz, D.; Mulligan, M. J.; Goepfert, P.; Fast, P.; Berman, P.; Powell, M.; Francis, D. Vaccine 2001, 19, 2080.
15. Carcaboso, A. M.; Hernández, R. M.; Igartua, M.; Rosas, J. E.; Patarroyo, M. E.; Pedraz, J. L. Vaccine 2004, 22, 1423.
16. (a) Kim, Y.-J., Gin, D. Y. Org. Lett. 2001, 3, 1801-1804.
17. (b) Zhu, X.; Yu, B.; Hui, Y.; Schmidt, R. R. Eur. J. Org. Chem. 2004, 965.
18. Wang, P.; Kim, Y.-J.; Navarro-Villalobos, M.; Rohde, B. D.; Gin, D. Y. J. Am. Chem. Soc. 2005, 127, 3256-3257.
19. Nukada, T.; Berces, A.; Zgierski, M. Z.; Whitfield, D. M. J. Am. Chem. Soc. 1998, 120, 13291-13295.
20. Cleland, J. L.; Kensil, C. R.; Lim, A.; Jacobsen, N. E.; Basa, L.; Spellman, M.; Wheeler, D. A.; Wu, J.-Y. Powell, M. F. J. Pharm. Sci. 1996, 85, 22.
21. Elliot, D. F.; Kon, G. A. R. J. Chem. Soc. 1939, 1130-1135.
22. (a) Di Bussolo, V.; Kim, Y.-J.; Gin, D. Y. J. Am. Chem. Soc. 1998, 120, 13515-13516.
23. (b) Honda, E.; Gin, D. Y. J. Am. Chem. Soc. 2002, 124, 7343-7352.
24. Nishimura, S.-I.; Nomura, S.; Yamada, K. Chem. Commun. 1998, 617.
25. (a) Garcia, B. A.; Poole, J. L.; Gin, D. Y. J. Am. Chem. Soc. 1997, 119, 7597-7598.
26. (b) Garcia, B. A.; Gin, D. Y. J. Am. Chem. Soc. 2000, 122, 4269-4279.
27. Zinner, H.; Thielebeule, W. Chem. Ber. 1960, 93, 2791.
28. Shi, L.; Kim, Y.-J.; Gin, D. Y. J. Am. Chem. Soc. 2001, 123, 6939-6940.
29. David, S.; Hanessian, S. Tetrahedron 1985, 41, 643.
30. Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503-1531.
31. Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21.
32. Ho, P.-T. Can. J. Chem. 1979, 57, 381.
33. Nguyen, H. M.; Poole, J. L.; Gin, D. Y. Angew. Chem., Int. Ed. 2001, 40, 414.
34. Fukase, K.; Hase, S.; Ikenaka, T.; Kusumoto, S. Bull. Chem. Soc. Jpn. 1992, 65, 436.
35. Nicolaou, K. C.; Hummel, C. W.; Nakada, M.; Shibayama, K.; Pitsinos, E. N.; Saimoto, H.; Mizuno, Y.; Baldenium, K.-U.; Smith, A. L. J. Am. Chem. Soc. 1993, 115, 7625-7635.
36. The specific reason for the high β-selectivity in the glycosylation of 43 in the absence of the C2-participatory group in 45 is unclear, although it is likely that this outcome is highly substrate dependent.
37. Noyori, R.; Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. J. Am. Chem. Soc. 1987, 109, 5856-5858.
38. Brown, H. C.; Bhat, K. S. J. Am. Chem. Soc. 1986, 108, 5919-5931.
39. (a) White, J. D.; Hong, J.; Robarge, L. A. Tetrahedron Lett. 1999, 40, 1463.
40. (b) Blakemore, P. R.; Browder, C. C.; Hong, J.; Lincoln, C. M.; Nagornyy, P. A.; Robarge, L. A.; Wardrop, D. J.; White, J. D. J. Org. Chem. 2005, 70, 5449-5460.
41. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989.
42. Ishihara, K.; Yamamoto, H. Eur. J. Org. Chem. 1999, 527.
43. Ishihara, K.; Hanaki, H.; Yamamoto, H. Synlett 1993, 577.
44. Ishihara, K.; Hanaki, H.; Funahashi, M.; Miyata, M.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1995, 68, 1721-1730.
45. Ishihara, K.; Hanaki, H.; Yamamoto, H. Synlett 1995, 721-722.
46. Roush, W. R.; Bennett, C. E.; Roberts, S. E. J. Org. Chem. 2001, 66, 6389-6393.
47. The strategy of using 2,3-di-O-benzylidine-5-O-benzylapiofuranose instead of 76 as a the glycosyl donor for direct coupling with 52 was less attractive, given that such a donor required its preparation from 76 in a low-yielding sequence. Given that the conversion of 52 + 76 → → 77 is nearly quantitative over three steps, the alternate approach would have been considerably less efficient.
48. Braun, M.; Waldmuller, D. Synthesis 1989, 856.
49. 1H NMR, and MS data of synthetic S were identical to those of natural S, obtained by RP-HPLC of Quil A (Accurate Chemical & Scientific Corp.), a Quillaja extract known to contain traces of 5.